european psychiatric association

Psychopharmacology

Section committee

MOHR Pavel MOHR Pavel , Chair
Stuhec Matej Stuhec Matej, Co-Chair
BARTOVA Lucie BARTOVA Lucie, Secretary


Section mission

This Section's mission is to:

Section's mission is to present the benefits and risks of psychopharmacological treatment of mental disorders. The main activities are based on general and clinical pharmacology and their association with clinical trials and prudent medication use in daily practice. 

Section objectives

  1. To increase interest in psychopharmacology
  2. To present benefits and risks of psychopharmacological treatment
  3. To present newest psychopharmacological treatment

Annual reports

Future Activities

business meeting

Section Business Meeting
Section Business Meeting
28 March 2026 - 31 March 2026 / 34th EPA Congress, Peague (Czechia)
Description :

The section will hold one in-person meeting during the annual EPA Congress in Prague, Czechia, on 29th March 2026.

course

Course: Pharmacotherapy of depression (and beyond): the art of prescribing antidepressants
Course: Pharmacotherapy of depression (and beyond): the art of prescribing antidepressants
28 March 2026 - 28 March 2026 / 34th EPA Congress, Peague (Czechia)
Description :

This course has already been accepted.

This is session organized by the Section on Psychopharmacology.

Date: 28.03.2026 | 13:30 - 17:00 | South Room 223+4

Code: CO06

Topic: Educational

Chairs: Pavel Mohr (Czech Republic), Lucie Bartova (Austria)

Description: This interactive, evidence-based course is a “follow-up” of the previous popular course on antipsychotic treatment, organised by the Psychopharmacology Section at several past EPA Congresses. The primary target audience is early career psychiatrists, but it may be also of interest to more experienced prescribers who want to deepen their knowledge and become familiar with the latest developments in the field. The course is divided into several topics that cover novel nomenclature of antidepressants, (NbN), their pharmacology, clinical efficacy and safety, potential drug-drug interactions, treatment in specific situations (children and adolescents, elderly), evaluation of treatment response, management of non-response. In addition to the antidepressant drugs, other treatment interventions (herbal remedy, neurostimulation, psychedelics) will be briefly discussed.

symposium

Joint Sympoisum: Coming of age: pharmacotherapy during transition from adolescence to adulthood
Joint Sympoisum: Coming of age: pharmacotherapy during transition from adolescence to adulthood
29 March 2026 - 29 March 2026 / 34th EPA Congress, Peague (Czechia)
Description :

This session has already been accepted.
-          This is a joint symposium organized by the Section on
            Psychopharmacology and the Section on Child- and Adolescent
            Psychiatry.

Date: 29.03.2026 | 08:00 - 09:30 | South Hall 1A + South Hall 1B

Code: SP02

Topic: Clinical/Therapeutic

Chairs: Judit Balazs (Hungary), Pavel Mohr (Czech Republic) Speakers: Celso Arango (Spain), Judit Balazs (Hungary), Pavel Mohr (Czech Republic), Hana Papezova (Czech Republic)

Speakers: Celso Arango (Spain), Judit Balazs (Hungary), Pavel Mohr (Czech Republic), Hana Papezova (Czech Republic)

Presentation titles:

Present and future treatments in ASD. What we have and what we need (Speaker: Celso Arango, Spain)

Antidepressant treatment during transition from adolescence to adulthood (Speaker: Judit Balazs, Hungary)

Antipsychotics during transition from adolescence to adulthood (Speaker: Pavel Mohr, Czech Republic)

Pharmacotherapy of Eating Disorders during transition from adolescence to adulthood (Speaker: Hana Papezova, Czech Republic)

symposium

Core Symposium: Pharmacological aspects in diverse groups
Core Symposium: Pharmacological aspects in diverse groups
29 March 2026 - 29 March 2026 / 34th EPA Congress, Peague (Czechia)
Description :

This core symposium has already been accepted.

Date: 29.03.2026 | 17:00 - 18:30 | South Hall 3

Code: CRS03

Topic: Educational

Chairs: Jerzy Samochowiec (Poland), Simavi Vahip (Turkey)

Speakers: Dinesh Bhugra (United Kingdom), Eva Döring-Brandl (Germany), Pavel Mohr (Czech Republic), Meryam Schouler-Ocak (Germany)

workshop

How to start the rest of your career as a psychiatrist: A few words with those who made it
How to start the rest of your career as a psychiatrist: A few words with those who made it
30 March 2026 - 30 March 2026 / 34th EPA Congress, Peague (Czechia)
Description :

This worskhop has already been accepted.

This is a workshop organized by the Section on Early Career Psychiatrists.

Date: 30.03.2026 | 17:00 - 18:30 | Terrace 2A

Code: ECP07

Topic: Educational

Chairs: Federico Mucci (Italy), Giulio Longo (Italy)

Speakers: Sinan Guloksuz (Netherlands), Cécile Hanon (France), Fabian Kraxner (Switzerland), Pavel Mohr (Czech Republic)

workshop

Case-based Workshop: Clinical insights into drug-drug interactions: prescribing recommendations for daily practice
Case-based Workshop: Clinical insights into drug-drug interactions: prescribing recommendations for daily practice
31 March 2026 - 31 March 2026 / 34th EPA Congress, Peague (Czechia)
Description :

This worskhop has already been accepted.

This is a joint workshop organized by the Section on Psychopharmacology and the Section on Old Age Psychiatry.

Date: 31.03.2026 | 10:00 - 11:30 | Forum Hall

Code: CBS04

Topic: Pharmacology

Chairs: Matej Stuhec (Slovenia), Gabriela Stoppe (Switzerland)

Speakers: Georgios Schoretsanitis (Switzerland), Matej Stuhec (Slovenia), Pavel Mohr (Czech Republic), Gabriela Stoppe, (Switzerland), Istvan Bitter (Hungary),  Cécile Hanon (France)

Presentation titles:

Clinical case and drug-drug interactions in the elderly: a case report (Speaker: Georgios Schoretsanitis, Switzerland)

Pharmacokinetic and Pharmacodynamic Interactions: From Theory to Practice (Speaker: Matej Stuhec, Slovenia)

Assessing Drug-Drug Interactions in Adjunctive Antidepressant Treatment: Clinical Perspectives (Speaker: Pavel Mohr, Czech Republic)

Pharmacological Challenges and Clinical Strategies in Adjunctive Dementia Therapy based on Drug-Drug Interactions (Speaker: Gabriela Stoppe, Switzerland)

Evaluating Drug-Drug Interactions in Adjunctive Antipsychotic Therapy (Speaker: Istvan Bitter, Hungary)

Drug-drug interactions in nursing homes (Speaker: Cécile Hanon, France)

workshop

Psychiatrist treatment choices vs. Guidelines in the treatment of schizophrenia in different phases and clinical situations
Psychiatrist treatment choices vs. Guidelines in the treatment of schizophrenia in different phases and clinical situations
31 March 2026 - 31 March 2026 / 34th EPA Congress, Peague (Czechia)
Description :

This worskhop has already been accepted.

Date: 31.03.2026 | 08:00 - 09:30 | Forum Hall

Code: WS09

Topic: Clinical/Therapeutic

Chairs: Martina Rojnic Kuzman (Croatia), Peter Falkai (Germany)

Speakers: Pavel Mohr (Czech Republic), Silvana Galderisi (Italy), Angelika Wieck, United Kingdom), Martina Rojnic Kuzman (Croatia), Peter Falkai (Germany), Merete Nordentoft (Denmark)

Presentation titles:

Evidence-based treatment for treatment resistant schizophrenia (Speaker: Pavel Mohr, Czech Republic)

Evidence-based treatment of negative and cognitive symptoms in schizophrenia (Speaker: Silvana Galderisi, Italy)

How to manage pregnancy in schizophrenia (Speaker: Angelika Wieck, United Kingdom)

Psychiatrist schizophrenia treatment choices vs. guidelines: Results from the Ambassador study (Speaker: Martina Rojnic Kuzman, Croatia)

Evidence-based treatment for metabolic side-effects of antipsychotics (Speaker: Peter Falkai, Germany)

Evidence-based treatment in prodromal phase of schizophrenia (Speaker: Merete Nordentoft, Denmark)